Down syndrome can be identified before birth through prenatal screening and testing, or after birth through a combination of physical features and a confirmatory blood test. About 5,700 babies are born with Down syndrome in the United States each year, roughly 1 in every 640 births. Whether you’re currently pregnant and reviewing screening options or looking at your newborn and wondering about certain features, here’s what the process looks like at each stage.
Prenatal Screening in the First Trimester
The American College of Obstetricians and Gynecologists recommends that all pregnant patients be offered the option to screen for common chromosomal conditions, including Down syndrome. Screening doesn’t give a definitive yes or no. Instead, it estimates your baby’s risk level so you can decide whether to pursue further testing.
The most common first-trimester approach combines two things: a blood test measuring specific proteins and hormones, and an ultrasound measurement called nuchal translucency (NT). During the ultrasound, performed between 11 and 13 weeks, a technician measures a small pocket of fluid at the back of the baby’s neck. All babies have some fluid there, but a thicker-than-expected measurement raises the probability of Down syndrome. When the measurement exceeds 4.0 mm, the screening is essentially always positive regardless of maternal age. For women over 42, the threshold drops considerably, to as low as 1.8 mm at 11 weeks. For women under 35, there are also lower thresholds below which the screening is reliably negative. Your age, the NT measurement, and your blood work are combined into a single risk score.
Cell-Free DNA Screening (NIPT)
A newer and more accurate screening option is cell-free DNA testing, sometimes called noninvasive prenatal testing or NIPT. This is a simple blood draw, available as early as 10 weeks, that analyzes small fragments of placental DNA circulating in your bloodstream. For Down syndrome specifically, NIPT has a detection sensitivity of 100% in large studies, with a false positive rate of just 0.03%. That means it catches virtually all cases while rarely flagging a pregnancy that doesn’t actually have Down syndrome.
Even with those impressive numbers, NIPT is still a screening test. Its positive predictive value for Down syndrome is around 84%, meaning that about 16 out of 100 people who get a positive NIPT result will find out after diagnostic testing that the baby does not have the condition. A positive screen always needs confirmation.
Diagnostic Testing: Getting a Definitive Answer
If screening results come back high-risk, two procedures can confirm or rule out Down syndrome with near-complete accuracy. Chorionic villus sampling (CVS) is performed between 10 and 13 weeks by taking a tiny sample of placental tissue. Amniocentesis, done between 15 and 20 weeks, involves drawing a small amount of amniotic fluid with a needle guided by ultrasound. Both tests allow a lab to examine the baby’s actual chromosomes.
The main concern with these procedures is a small risk of pregnancy loss. Recent estimates put the procedure-related miscarriage risk for both CVS and amniocentesis at approximately 0.2 to 0.3%, or roughly 1 in 300 to 1 in 500 procedures. That risk is much lower than older estimates suggested, and it’s a key factor when deciding whether to proceed after a positive screen.
Physical Signs Noticed at Birth
Many babies with Down syndrome are identified in the delivery room or newborn nursery based on a recognizable pattern of physical features. No single feature is unique to Down syndrome, and many of these traits can appear in babies without the condition. But when several appear together, they prompt further evaluation. Common signs include:
- Low muscle tone (hypotonia): The baby may feel unusually floppy or limp when held.
- Flattened facial profile: The bridge of the nose and the face overall appear flatter than typical.
- Upward-slanting eyes: Often with a small skin fold covering the inner corner of the eye.
- Small head, ears, and mouth
- Short neck with extra skin at the back
- A single deep crease across the palm instead of the typical two lines
- Wide, short hands with short fingers
- A wide gap between the first and second toes
- Brushfield spots: Small white or light-colored flecks on the colored part of the eye
Some of these features are subtle, and not every baby with Down syndrome will have all of them. A baby who looks “different” to a parent or nurse isn’t necessarily affected, and conversely, milder cases (particularly mosaic Down syndrome) can be easy to miss on physical exam alone.
Confirming the Diagnosis After Birth
When Down syndrome is suspected based on physical features, a blood test called a karyotype confirms the diagnosis. A lab draws a small blood sample from the baby, grows the cells, then photographs and arranges the chromosomes by size, number, and shape. A baby with Down syndrome will have three copies of chromosome 21 instead of the usual two. Results typically take one to two weeks.
The karyotype also reveals which type of Down syndrome is present. In 90 to 95% of cases, the baby has full trisomy 21, meaning every cell carries an extra chromosome. About 2 to 4% of cases are mosaic, where only some cells have the extra chromosome. These individuals sometimes have milder features. Another 1 to 5% result from a translocation, where part of chromosome 21 attaches to another chromosome. The translocation type matters for family planning because it can sometimes be inherited from a parent.
Health Screenings in the First Days
A Down syndrome diagnosis triggers a specific set of medical evaluations in the newborn period, because certain health conditions are significantly more common. About 50% of babies with Down syndrome have a heart defect, so an echocardiogram (heart ultrasound) is typically performed before the baby leaves the hospital, ideally read by a pediatric cardiologist. Doctors also check for intestinal blockages, cataracts, feeding difficulties, and reflux. Blood work screens for thyroid problems and a temporary blood cell disorder. Newborn hearing screening results are reviewed closely, since hearing loss is more common in this group.
Many of these conditions are treatable, especially when caught early. A heart defect that would go unnoticed for weeks in another baby gets identified and managed right away because of the targeted screening.
Early Developmental Differences
If you’re watching a baby who hasn’t been formally tested and wondering whether their development looks typical, milestone timelines can offer some context. Babies with Down syndrome reach the same milestones as other children, but on a wider and later timeline. A baby without Down syndrome typically sits alone by 5 to 9 months; a baby with Down syndrome may sit independently anywhere from 6 to 36 months. Walking independently happens between 9 and 18 months for most children, but the range extends from 1 to 4 years for children with Down syndrome. First words usually appear between 1 and 4 years, compared to 1 to 2 years typically.
These ranges are wide because there’s enormous variation among children with Down syndrome. Low muscle tone is the most consistent early sign, and it’s often what parents notice first: the baby may have difficulty holding their head up, seem less active during tummy time, or feed slowly. A responsive social smile, one of the earliest milestones, appears between 1 and 5 months, which overlaps significantly with the typical range of 1 to 3 months.
Early intervention programs, which include physical therapy, speech therapy, and occupational therapy, can meaningfully narrow the gap on many of these milestones. Most states offer these services at no cost through early intervention programs, and they can begin in the first weeks of life.
Why Screening and Testing Timelines Matter
Prenatal screening gives families time to prepare, whether that means arranging for delivery at a hospital with a pediatric cardiologist on staff, connecting with support organizations, or simply processing the news before the baby arrives. Families who learn about a diagnosis prenatally often report feeling more confident and less overwhelmed in the newborn period.
For families who didn’t have prenatal screening, or whose screening came back low-risk (no test is perfect), the diagnosis may come in the delivery room or even weeks later if features are subtle. Either way, the karyotype blood test provides a clear answer, and the same health screenings and early intervention services are available regardless of when the diagnosis happens.